CRAYON
Every story · every side  ·  est. 1995
U.S.

New drug combo shrinks tumors in most patients facing aggressive cancer type

Photo: Fox News
CRAYON summary

Fox News reports that a daily pill called daraxonrasib, given alongside chemotherapy in a pancreatic cancer trial, shrank tumors in 60.7% of patients and halted tumor growth in 90.2%, according to researchers. The outlet adds that 8.2% of patients saw their tumors disappear on scans.

Based on Fox News's report - only one outlet has covered this so far. Read the original.
▲ Sign in to vote stories up

Coverage 1 source · 1 report

Chronological.

  1. Fox News FIRST 47m ago New drug combo shrinks tumors in most patients facing aggressive cancer type

    The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, with 8.2% seeing tumors vanish on scans.

Discussion 0 comments